Modified GRF(1-29) vs L-692,429

Head-to-head comparison of Modified GRF(1-29) ([D-Ala2, Nle27]-human growth hormone-releasing hormone (1-29) amide) and L-692,429 (L-692,429) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyModified GRF(1-29)L-692,429
CategoryGrowth HormoneGrowth Hormone
Full Name[D-Ala2, Nle27]-human growth hormone-releasing hormone (1-29) amideL-692,429
Molecular WeightN/AN/A
Half-Life10-30 minutesunknown / study-dependent
Amino Acids29N/A
Typical Dose50-300 mcg0.03-0.1 mg/kg
RouteSubcutaneousOral
Purity≥98%≥98%
Studies Count15030
Research StatusInvestigationalPre-clinical

Modified GRF(1-29) Benefits

  • enhanced GH release
  • greater peptide stability
  • IGF-1 support research
  • longer receptor engagement

L-692,429 Benefits

  • potent GHSR agonism
  • oral bioactivity in models
  • validates ghrelin pathway
  • useful research probe

Modified GRF(1-29) Dosing

50-100 mcg SC for acute GH-response studies|100-300 mcg SC in monitored research protocols|repeat dosing in short investigative cycles with GH/IGF-1 tracking

L-692,429 Dosing

0.03-0.1 mg/kg in early studies|single oral or short-course research dosing|serial GH sampling recommended

Modified GRF(1-29) Side Effects

  • headache
  • water retention
  • injection-site irritation

L-692,429 Side Effects

  • increased appetite
  • glucose intolerance
  • transient prolactin changes

Research Overview

Modified GRF(1-29)

Modified GRF(1-29) has been studied as a practical GHRH analog for boosting GH release while improving peptide stability versus the native fragment. It is a standard reference compound in experimental work on growth hormone pulsatility and analog design.

L-692,429

L-692,429 was important in early GH secretagogue research because it showed that nonpeptide molecules could trigger robust GH release. It remains a classic tool compound for studying receptor-mediated GH pulsatility and appetite signaling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Modified GRF(1-29) stacks with:

L-arginineL-ornithineglycine

L-692,429 stacks with:

Receptor assaysEndocrine studies
ghrh-analogsynthetic-peptidegrowth-hormoneresearch-compoundtool-compoundgh-secretagogueghrelin-pathway